» Articles » PMID: 33508893

Preoperative Predictors of Restoration in Quality of Life After Surgery for Lung Cancer

Overview
Journal Thorac Cancer
Date 2021 Jan 28
PMID 33508893
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The preoperative predictors of quality of life (QOL) in patients who undergo lung resection for lung cancer are poorly known. Here, we investigated these predictors in such patients using two QOL measures.

Methods: In this single-institutional prospective cohort study, we administered the EQ-5D-5 levels (EQ-5D-5L) from January 2015, and the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire with 30 items from April 2015 to April 2018 preoperatively (Pre) and at one month postoperatively (M1), and one year postoperatively (Y1). General health status was measured by the EQ-5D visual analogue scale (VAS) and EORTC global health status/QOL (GHS) scores. Multivariable linear regression analyses were used to explore the preoperative predictors of QOL at Y1.

Results: A total of 223 patients were included in the study. The EQ-5D VAS and EORTC GHS scores, at Pre, M1, and Y1, were 80 ± 15, 77 ± 15, and 84 ± 11; and 74 ± 19, 65 ± 20, and 78 ± 17, respectively. In the multivariable analyses, the albumin level, preoperative VAS score, and preoperative pain/discomfort and anxiety/depression were identified as predictors by the EQ-5D VAS score. The preoperative EORTC GHS score, absence of diabetes mellitus, preoperative cognitive function score, and preoperative symptom score of pain were identified as predictors by the EORTC GHS score.

Conclusions: The EQ-5D VAS and EORTC GHS scores traced similar trajectories of QOL. In both QOL measures, preoperative pain was found as a common predictor. These predictors may help improve patient/survivor care in the future.

Citing Articles

The mediating role of medical coping modes between stigma and quality of life in patients undergoing lung cancer surgery: a cross-sectional study.

Ma F, Zheng W, Wang W, Zhang N, Liu Y BMC Cancer. 2024; 24(1):1561.

PMID: 39707246 PMC: 11660735. DOI: 10.1186/s12885-024-13337-9.


Operation room nursing based on humanized nursing mode combined with nitric oxide on rehabilitation effect after lung surgery.

Wang Q, Wang Z, Zhu J World J Clin Cases. 2024; 12(18):3368-3377.

PMID: 38983410 PMC: 11229898. DOI: 10.12998/wjcc.v12.i18.3368.


Maintaining quality of life after major lung resection for carcinoid tumor.

Jalil R, Abdallah F, Obeid Z, Abou Chaar M, Harb A, Shannies T J Cardiothorac Surg. 2023; 18(1):330.

PMID: 37964297 PMC: 10648721. DOI: 10.1186/s13019-023-02435-7.


[Application of Precision Nursing Based on Multidisciplinary Collaboration Model in Older Patients Undergoing Thoracoscopic Surgery for Lung Cancer].

Mei S, Wu X, Yang J, Yu Z, Jiang Y, Xue Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2023; 54(5):1052-1057.

PMID: 37866968 PMC: 10579088. DOI: 10.12182/20230960508.


Comparison of patient-reported outcomes and clinical outcomes between pleurectomy and pleural covering added to thoracoscopic bullectomy for primary spontaneous pneumothorax.

Kobayashi K, Ichimura H, Kawabata S, Suzuki H, Endo K, Kobayashi N J Thorac Dis. 2023; 15(7):3818-3828.

PMID: 37559634 PMC: 10407504. DOI: 10.21037/jtd-23-214.


References
1.
Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K . A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011; 6(4):751-6. DOI: 10.1097/JTO.0b013e31821038ab. View

2.
Kenny P, King M, Viney R, Boyer M, Pollicino C, McLean J . Quality of life and survival in the 2 years after surgery for non small-cell lung cancer. J Clin Oncol. 2007; 26(2):233-41. DOI: 10.1200/JCO.2006.07.7230. View

3.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

4.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View

5.
Vijayvergia N, Shah P, Denlinger C . Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward. J Natl Compr Canc Netw. 2015; 13(9):1151-61. PMC: 5450910. DOI: 10.6004/jnccn.2015.0140. View